Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A virus-free immunogen effective against Epstein-Barr virus

Abstract

Epstein–Barr virus (EBV)-associated diseases—infectious mononucleosis (IM), nasopharyngeal carcinoma (NPC) and Burkitt's lymphoma (BL)—constitute considerable world health problems. EBV infection occurs in all human populations and is accompanied by seroconversion and life-long persistence of the virus1. The antibodies present as a consequence of infection are considered important in controlling the persistent viral infection and in preventing recurrent bouts of IM which is known to be caused by the virus2. As EBV infection during childhood does not usually result in illness20, only seronegative adolescents and young adults are susceptible to IM. Similarly, the groups at risk to EBV-associated neoplasms are known. The first group includes children in areas of hyper- and holoendemic malaria in Africa3, where BL is the most common childhood cancer. The other group consists of people, particularly men, of the HLA-2 and Sin 2 haplotypes4, of southern Chinese origin amongst whom NPC is the most common tumour5. It has been suggested that an anti-EBV vaccine should be developed6, and this debate has been stimulated recently by a study further implicating EBV with African BL7. I report here the successful production of a DNA-free immunogen which may be readily prepared in large quantities and will successfully invoke a strong neutralising anti-EBV response in experimental animals. This material could form the basis for developing an anti-EBV vaccination programme.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hewetson, J. F., Rocchi, G., Henle, W. & Henle, G. J. infect. Dis. 128, 283–289 (1973).

    Article  CAS  Google Scholar 

  2. Niederman, J. C., Evans, A. S., Subrahmanyan, L. & McCollumn, R. W. New Engl.J.Med. 282, 361–365 (1970).

    Article  CAS  Google Scholar 

  3. Burkitt, D. J. natn. Cancer Inst. 42, 19–28 (1969).

    CAS  Google Scholar 

  4. Simons, M.J. et al. Oncogenesis and Herpesviruses II Part 2 (eds Epstein, M.A., de-Thé, G. & zur Hausen, H.) 249–257 (IARC, Vienna, 1975).

    Google Scholar 

  5. Shanmugaratnam, K. Int. Rev. exp. Pathl. 10, 361–382 (1971).

    CAS  Google Scholar 

  6. Epstein, M. A. Cancer Res. 36, 711–714 (1976).

    CAS  PubMed  Google Scholar 

  7. de-Thé, G. et al. Nature 274, 756–761 (1979).

    Article  ADS  Google Scholar 

  8. Lesnick, F. & Ross, L. J. N. Int. J. Cancer 16, 153–163 (1975).

    Article  Google Scholar 

  9. Laufs, R. & Steinke, H. Nature 252, 71–72 (1975).

    Article  ADS  Google Scholar 

  10. Thorley-Lawson, D. A. Cell 16, 33–42 (1979).

    Article  CAS  Google Scholar 

  11. Thorley-Lawson, D. A. & Edson, C. J. Virol. (in the press).

  12. Warburg, O. & Christian, W. Biochem. Z. 310, 384–421 (1941).

    Google Scholar 

  13. Spurdari, S. & Weissbach, A. J. biol. Chem. 249, 5809–5815 (1974).

    Google Scholar 

  14. Dulley, J. R. & Grieve, P. A. Analyt. Biochem. 64, 136–141 (1975).

    Article  CAS  Google Scholar 

  15. Burton, K. Meth. Enzym. XII, 163–166 (1968).

    Article  Google Scholar 

  16. Thorley-Lawson, D. A., Chess, L. & Strominger, J. L. J. exp. Med. 146, 495–507 (1977).

    Article  CAS  Google Scholar 

  17. Miller, G., Shope, T., Lisco, H., Stitt, D. & Lipman, H. Proc. natn. Acad. Sci. U.S.A. 69, 383–387 (1972).

    Article  ADS  CAS  Google Scholar 

  18. Crumpton, M. J. & Snary, D., Contemp. Topics molec. Immun. 3, 27–56 (1974).

    Article  CAS  Google Scholar 

  19. Pearson, G. R. & Qualitiere, L. F. J. Virol. 28, 344–351 (1978).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Henle, G. & Henle, W. J. infect. Dis. 121, 303–310 (1970).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Thorley-Lawson, D. A virus-free immunogen effective against Epstein-Barr virus. Nature 281, 486–488 (1979). https://doi.org/10.1038/281486a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/281486a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing